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Abstract
Background: Primary malignancies of colorectal origin can metastasise to the bladder. Reports
are however extremely rare, particularly from the caecum.
Case report: The report describes the case of a 45-year old male with Duke's B caecal carcinoma
treated with a laparoscopically-assisted right hemicolectomy and adjuvant 5-Fluorouracil
chemotherapy. Subsequently, a metastatic lesion to the bladder was demonstrated and successfully
excised by partial cystectomy.
Conclusion: In order that optimal therapeutic options can be determined, it is important for
clinicians to distinguish between primary disease of the bladder and other causes of haematuria.
Various immunohistochemical techniques attempt to differentiate primary adenocarcinoma of the
bladder from secondary colorectal adenocarcinoma. Suspicion of metastatic disease must be raised
when histologically unusual bladder tumours are identified.
Background
The vast majority of bladder tumours are primary transi-
tional cell carcinomas. Primary adenocarcinomas of the
bladder are rarer but well recognized. Secondary neoplas-
tic growths of the bladder account for approximately 2%
of bladder malignancies [1]. Bladder involvement in
patients with primary colorectal adenocarcinomas is most
likely to be secondary to direct invasion from the adjacent
recto-sigmoid. Isolated distant metastases to the bladder
from colorectal primary disease have very rarely been
reported [2-5]. This case presents a case of frank haematu-
ria related to a bladder metastasis from a mucinous aden-
ocarcinoma of the caecum.
Case presentation
A 45-year-old man presented with vague abdominal pain
associated with a palpable mass. An ultrasound scan dem-
onstrated a mass in the right iliac fossa but no evidence of
hepatic metastases or lymphadenopathy. A plain X-ray
film of the chest demonstrated no abnormality. A subse-
quent barium enema suggested a caecal carcinoma and he
was subsequently treated for a pT3 N0 M0 (Dukes B)
moderately differentiated mucinous adenocarcinoma of
the caecum in July 2002 with a laparoscopically-assisted
right hemicolectomy. A complete oncological resection
was achieved with clear surgical resection margins of at
least 4 centimetres. Fourteen lymph nodes were sampled
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with his high risk for microsatellite instability, he under-
went 30 sessions of weekly adjuvant 5-Fluorouracil (5-
FU) chemotherapy with minimal co-morbidity. Eight
months post-operatively he was referred to the Urology
Department with a 4-month history of irritative lower uri-
nary tract symptoms that had culminated with a short his-
tory of frank haematuria.
An initial flexible cystoscopy revealed a solid-looking 2
cm growth on the posterior bladder wall. A subsequent
intravenous urogram demonstrated normal upper tracts.
He underwent trans-urethral resection of the bladder
tumour (TURBT) through to deep muscle. Histology of
the TURBT specimen revealed a moderately differentiated
adenocarcinoma with the following immunoprofile:
CK20 and CDX2 +ve, but CK7 -ve. This tissue contained
no evidence of extensive cystitis cystica glandularis, intes-
tinal metaplasia or any in-situ component, as may be seen
in a primary bladder adenocarcinoma. Comparison was
made with the original caecal pathology. Morphologically
and immunohistochemically these specimens were iden-
tical, suggesting bladder metastases from the primary cae-
cal malignancy (Figure 1). A computed tomography (CT)
scan at this time revealed no sign of further metastatic dis-
ease. The Oncology Department arranged for him to
receive CT-staged 3-D conformal multi-fractionated radi-
otherapy to a total dose of 56 Gray (Gy).
Ten months following the original TURBT, recurrent blad-
der tumour was found in the same position at check cys-
toscopy. This was confirmed to be recurrent moderately
differentiated intestinal-type adenocarcinoma. Magnetic
Resonance scanning revealed a mass involving the right
antero-lateral bladder wall and dome extending to the
perivesical fat and the right vas deferens. Review of the
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suggested the lesion to actually be stage pT2b with associ-
ated post-TURBT perivesical inflammatory changes. There
was no evidence of lymphadenopathy or metastatic dis-
ease. Furthermore neither recurrent colon tumour nor any
direct involvement between bowel and bladder were iden-
tified. Subsequently he was offered and underwent a par-
tial cystectomy (Figures 2 and 3). There was no evidence
of recurrent disease at twelve-month review.
Discussion
Distant metastases to the bladder have been reported in
patients with primary stomach [2,6], skin [2,7,8], breast
[2,9-11], lung [2], pancreatic [2,12], uterine [2,13] and
oesophageal malignancies [14]. Caecal primaries are ana-
tomically less likely to invade the bladder than neoplasms
of the rectosigmoid. This rare case provides evidence con-
sistent with distant metastases to the bladder which were
subsequently treated surgically with clear resection mar-
gins (Figure 3).
A correct distinction between primary adenocarcinoma of
the bladder and secondary colorectal adenocarcinoma is
important for staging of disease, determining appropriate
treatment and ultimate prognosis [15]. In this case, the
patient had already received treatment for a caecal
tumour. If however the bladder metastasis was the pre-
senting feature, it would be important to identify and
evaluate the underlying primary in the colorectum.
Immunohistochemical similarities between primary ade-
nocarcinoma and secondary colorectal adenocarcinoma
of the bladder however make this task difficult [15,16].
As in this case, immunostains CK7 and CK20 are com-
monly used to aid diagnosis, with most lesions of colorec-
tal origin having a CK7 negative and CK20 positive profile
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previously published results [17], suggesting stains for
CK7 and CK20 were positive in greater than one half of
primary bladder adenocarcinoma tissue samples. The
authors however concluded that combined staining for
CK7 and CK20 alone did not provide sufficient specificity
for accurate differentiation between the two clinical sce-
narios. The investigators discussed the failure of the
tumour suppressor adenomatous polyposis coli (APC)
gene in colorectal tumorigenesis and the consequent rise
in the cell degradation product β-catenin. Nuclear stain-
ing of metastatic colonic carcinoma with β-catenin aids in
distinguishing primary from metastatic adenocarcinomas
with nuclear positivity in 81% of metastatic tumours com-
pared to less than 1% of primary carcinomas [15]. The
study by Wang et al. also suggested that thrombomodulin
expression as a marker of primary bladder carcinoma adds
to the specificity of the CK7 and CK20 profile. 59% of pri-
mary bladder adenocarcinomas demonstrated significant
expression of membranous thrombomodulin compared
to 0% of colonic adenocarcinomas [15]. CDX2 is a home-
obox transcription factor that regulates the differentiation
of intestinal epithelial cells. As in this case, it has been
shown to be of diagnostic use in aiding distinction
between primary adenocarcinoma of the bladder and sec-
ondary colorectal carcinoma [18]. Tamboli et al. also sug-
gested the use of stains for Villin and concluded that their
use, in addition to CK7 and CK20, allowed urothelial car-
cinoma with glandular differentiation to be distinguished
from secondary colonic carcinoma [19]. The available evi-
dence suggests that an immunohistochemical panel of
CK7, CK20, CDX2, beta-catenin, thrombomodulin and
Villin may best distinguish primary bladder adenocarci-
nomas from metastases. However, it should be noted that
in total the current literature contains relatively few cases
of primary bladder adenocarcinoma that have been eval-
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field is needed before a definitive panel that enables dis-
crimination between primary and metastatic bladder ade-
nocarcinomas can be established.
Conclusion
This case highlights the rare complication of a distant
bladder metastasis from a caecal carcinoma. This was suc-
cessfully treated with a surgical resection and the patient
had not suffered recurrence after twelve months of follow-
up. Suspicion of metastatic disease must be considered
when histologically unusual bladder tumours are identi-
fied. In the absence of pre-existing malignant disease
immunohistochemical panels of antibodies are often
required to try and identify the focus of primary disease
thus allowing appropriate treatment regimen to be formu-
lated.
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